| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$2,225,393 ) (Continued on the next page) |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23DA053433 | A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women | 000 | 4 | NIH | 3/21/2025 | $177,884 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AR081270 | Development of Injectable Super-Lubricious Microgels for Sustained Release of Platelet-Rich Plasma to Treat Post-Traumatic Osteoarthritis | 000 | 3 | NIH | 4/15/2025 | $443,939 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS119263 | Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | 000 | 5 | NIH | 4/15/2025 | $351,855 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 003 | 29 | NIH | 4/15/2025 | $461,348 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23AR079035 | Neighborhood Barriers and Facilitators to Walking, the Epidemiology of Knee Osteoarthritis and Developing Effective Exercise Prescriptions | 000 | 4 | NIH | 4/1/2025 | $157,393 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 000 | 9 | NIH | 3/28/2025 | $432,620 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 007 | 6 | NIH | 2/12/2025 | $2,228,484 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 007 | 6 | NIH | 2/12/2025 | $564,238 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089917 | Cathepsin-L mediated remodeling of the nuclear proteome | 000 | 1 | NIH | 11/13/2024 | $227,250 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 3 | NIH | 12/6/2024 | $53,974 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 001 | 2 | NIH | 12/5/2024 | $334,821 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 3 | NIH | 12/17/2024 | $462,823 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K22CA279495 | Elucidating Mechanisms of CAR ML NK cell biology to treat cancer and infection | 000 | 2 | NIH | 12/18/2024 | $186,030 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 5 | NIH | 2/13/2025 | $661,369 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 3 | NIH | 12/12/2024 | $484,531 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21NS137054 | Unraveling how neuropathic pain synaptic transcriptome is signaled by G-quadruplex folds | 000 | 2 | NIH | 2/14/2025 | $227,250 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21HL173848 | Introducing NanoProTEN, a novel approach for anticoagulation in patients with prothrombotic autoantibodies | 000 | 2 | NIH | 4/8/2025 | $189,375 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM154323 | Mechanism of homologous recombination driven by the intrinsically disordered domain of tumor suppressor PALB2 | 000 | 2 | NIH | 4/8/2025 | $303,000 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL139554 | Structural enzymology of protein C | 000 | 8 | NIH | 4/14/2025 | $485,833 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DC019566 | Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds | 000 | 4 | NIH | 3/27/2025 | $464,064 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI142672 | Innate immune response of LTBI+HIV+ children | 003 | 5 | NIH | 3/31/2025 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 002 | 28 | NIH | 3/28/2025 | $93,194 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI142672 | Innate immune response of LTBI+HIV+ children | 002 | 5 | NIH | 2/12/2025 | $305,214 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 001 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 001 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q53678 | Geriatrics Workforce Enhancement Program | 03 | 1 | HRSA | 1/22/2025 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 000 | 1 | NIH | 11/19/2024 | -$146,530 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01DK061718 | The Saint Louis University Component of the NASH Clinical Research Network | 001 | 23 | NIH | 3/5/2025 | $120,945 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 000 | 28 | NIH | 3/26/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV) | 001 | 2 | NIH | 2/19/2025 | -$1 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL049413 | Structural basis of prothrombin activation | 001 | 27 | NIH | 3/28/2025 | -$93,194 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 001 | 2 | NIH | 2/12/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM141652 | Function and Regulation of a Novel Membrane-Associated Deubiquitinating Enzyme | 000 | 1 | NIH | 1/29/2025 | -$614 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG076812 | Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine. | 000 | 1 | NIH | 1/16/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R25AI170379 | NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations | 001 | 2 | NIH | 1/21/2025 | -$8,078 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA238705 | Defining how obesity shapes immunity and the success of cancer immunotherapy | 000 | 5 | NIH | 12/4/2024 | -$5,560 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 000 | 2 | NIH | 1/3/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30HL151136 | Mechanistic investigations of Granzyme A-mediated γ9δ2 T cell TB protective effects | 000 | 4 | NIH | 3/25/2025 | -$2,603 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | MC142100 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 03 | 3 | HRSA | 3/5/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 001 | 5 | NIH | 2/18/2025 | $2,581 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01DK061718 | The Saint Louis University Component of the NASH Clinical Research Network | 000 | 22 | NIH | 3/5/2025 | -$120,945 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | MC142100 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 04 | 3 | HRSA | 4/15/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS111120 | Novel therapeutic approaches for traumatic brain injury induced cognitive deficits | 000 | 4 | NIH | 4/9/2025 | -$28 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15DK132727 | Insulin sensitivity in skeletal muscle | 000 | 1 | NIH | 4/1/2025 | $0 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56HL165199 | Insulin regulation of lymphatic vessel integrity | 000 | 1 | NIH | 3/18/2025 | -$1,654 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI165081 | Mechanisms of retroviral integrase-DNA complexes assembly | 000 | 2 | NIH | 2/13/2025 | -$9,727 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 006 | 3 | NIH | 1/27/2025 | -$990,117 |
|
